These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7878696)

  • 1. Cyclosporin A monitoring in Australia: consensus recommendations.
    Morris RG; Tett SE; Ray JE
    Ther Drug Monit; 1994 Dec; 16(6):570-6. PubMed ID: 7878696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin monitoring in Australasia: survey of laboratory practices in 2000.
    Morris RG; Lam AK
    Ther Drug Monit; 2002 Aug; 24(4):471-8. PubMed ID: 12142629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian cyclosporin therapeutic monitoring method survey: 1993.
    Morris RG
    Ther Drug Monit; 1994 Dec; 16(6):564-9. PubMed ID: 7878695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines.
    Morris RG; Ilett KF; Tett SE; Ray JE; Fullinfaw RO; Cooke R; Cook S
    Ther Drug Monit; 2002 Dec; 24(6):677-88. PubMed ID: 12451282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT Joint Working Group.
    Morris RG; Holt DW; Armstrong VW; Griesmacher A; Napoli KL; Shaw LM;
    Ther Drug Monit; 2004 Apr; 26(2):227-30. PubMed ID: 15228170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay.
    Morris RG; Saccoia NC; Ryall RG; Peacock MK; Sallustio BC
    Ther Drug Monit; 1992 Jun; 14(3):226-33. PubMed ID: 1412609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood cyclosporin monitoring in liver and heart transplant patients: evaluation of the specificity of a fluorescence polarization immunoassay and an enzyme-multiplied immunoassay technique.
    Gulbis B; Van der Heijden J; van As H; Thiry P
    J Pharm Biomed Anal; 1997 Apr; 15(7):957-63. PubMed ID: 9160262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12th quality assessment of cyclosporin blood monitoring by 56 Japanese laboratories.
    Takagi H; Uchida K; Takahara S; Takahashi K
    Transplant Proc; 1998 Aug; 30(5):1706-8. PubMed ID: 9723250
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of two techniques of ciclosporine monitoring].
    Charfi R; El Jebari H; Gaïes E; Charfi O; Jebabli N; Thouraya R; Ben Messaouda M; Lakhal M; Klouz A; Salouage I; Trabelsi S
    Ann Biol Clin (Paris); 2015; 73(6):717-22. PubMed ID: 26635051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences with the enzyme-multiplied immunoassay cyclosporine specific assay in a therapeutic drug monitoring laboratory.
    Morris RG; Saccoia NC; Sallustio BC; Fergusson LK; Mangas S; Kassapidis C
    Ther Drug Monit; 1993 Oct; 15(5):410-3. PubMed ID: 8249048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?
    Witzke O; Heemann U; Thesing A; Wolfhard U; Erhard J; Philipp T; Michel MC
    Eur J Clin Pharmacol; 1997; 52(5):413-6. PubMed ID: 9272414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
    Royer B; Davani S; Bérard M; Kantelip JP; Muret P
    Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.
    Bergan S; Rugstad HE; Stokke O; Bentdal O; Frøysaker T; Bergan A
    Scand J Clin Lab Invest; 1993 Aug; 53(5):471-7. PubMed ID: 8210969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for monitoring cyclosporine in transplant recipients.
    Napoli KL; Kahan BD
    Clin Lab Med; 1991 Sep; 11(3):671-91. PubMed ID: 1934970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay.
    Butch AW; Fukuchi AM
    J Anal Toxicol; 2004 Apr; 28(3):204-10. PubMed ID: 15107152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of assay methods for cyclosporin. Clinical implications.
    Kivistö KT
    Clin Pharmacokinet; 1992 Sep; 23(3):173-90. PubMed ID: 1511535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S; Olejnik Y; Bonardet A; Garrigue V; Mourad G; Cristol JP; Dupuy AM
    Transplant Proc; 2005; 37(1):167-71. PubMed ID: 15808583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring.
    Morris RG
    Ther Drug Monit; 2000 Apr; 22(2):160-2. PubMed ID: 10774626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patients.
    Fatio R; Sütsch G; Pei P; Follath F; Kiowski W
    Clin Chem; 1998 Mar; 44(3):693-4. PubMed ID: 9510894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.